Yi Xing

Yi Xing has held a variety of roles in the biochemistry and biophysics fields since 2005. In 2004, they were a Postdoc Fellow in Wenqing Xu's Lab at the University of Washington. In 2005, they held a Postdoc Fellow in Stephen C Harrison's lab, Ruth L. Kirschstein National Research Service Award at Harvard Medical School. From 2011 to 2020, Yi Xing worked at Novartis as an Investigator II, where they led the immunogen design, production, purification and structural characterization efforts to support novel vaccine development, and managed and coached junior scientists to support preclinical studies and technology transfer to manufacturing. From 2015 to 2020, Yi Xing worked at the Broad Institute of MIT and Harvard, first as a Drug Discovery Project Leader, then as a Senior Research Scientist II & Protein Science Lead, and finally as a Senior Research Scientist I. In this role, they led venture-backed drug discovery projects, served as the project contact person to work with academia labs and industrial partners, and led the team to generate data for the next stage drug discovery efforts. They also led protein science/structural biology and managed junior scientists in Broad-Bayer cardiovascular disease collaboration and in Broad oncology projects to support the discovery and development of therapeutic small molecules and biologics. In 2021, Yi Xing joined FogPharma as the Director of Biochemistry & Senior Principle Scientist, where they led biochemistry & biophysics to support IND enabling of the pipeline project, and evaluated and led targeting strategy, protein sciences, structural biology, and assay establishment for one of the new targets. In 2022, Yi Xing was appointed as the Senior Director of Drug Creation, Head of Protein Sciences & Structural Biology at Seismic Therapeutic.

Yi Xing attained a Bachelor of Science in Chemistry from Sichuan University between 1993 and 1997. Yi then went on to pursue a Doctor of Philosophy in Protein Biochemistry and Structural Biology from the University of Washington, which they completed in 2004.